Fluoxymesterone, sold under the brand names Halotestin and Ultandren among others, is an androgen and anabolic steroid (AAS) medication which is used in the treatment of low testosterone levels in men, delayed puberty in boys, breast cancer in women, and anemia. It is taken by mouth.
Side effects of fluoxymesterone include symptoms of masculinization like acne, increased hair growth, voice changes, and increased sexual desire. It can also cause liver damage and cardiovascular side effects like high blood pressure. The drug is a synthetic androgen and anabolic steroid and hence is an agonist of the androgen receptor (AR), the biological target of androgens like testosterone and dihydrotestosterone (DHT). It has strong androgenic effects and moderate anabolic effects, which make it useful for producing masculinization.
Fluoxymesterone was first described in 1956 and was introduced for medical use in 1957. In addition to its medical use, fluoxymesterone is used to improve physique and performance. The drug is a controlled substance in many countries and so non-medical use is generally illicit.
|
Read full article at Wikipedia
|
InChI=1S/C20H29FO3/c1-17-8-6-13(22)10-12(17)4-5-15-14-7-9-19(3,24)18(14,2)11-16(23)20(15,17)21/h10,14-16,23-24H,4-9,11H2,1-3H3/t14-,15-,16-,17-,18-,19-,20-/m0/s1 |
YLRFCQOZQXIBAB-RBZZARIASA-N |
[H][C@]1(O)C[C@@]2(C)[C@@]([H])(CC[C@]2(C)O)[C@]2([H])CCC3=CC(=O)CC[C@]3(C)[C@@]12F |
|
anabolic agent
A compound which stimulates anabolism and inhibits catabolism. Anabolic agents stimulate the development of muscle mass, strength, and power.
(via anabolic androgenic steroid )
androgen
A sex hormone that stimulates or controls the development and maintenance of masculine characteristics in vertebrates by binding to androgen receptors.
(via anabolic androgenic steroid )
hormone
Originally referring to an endogenous compound that is formed in specialized organ or group of cells and carried to another organ or group of cells, in the same organism, upon which it has a specific regulatory function, the term is now commonly used to include non-endogenous, semi-synthetic and fully synthetic analogues of such compounds.
(via steroid hormone )
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
9-fluoro-11β,17β-dihydroxy-17α-methylandrost-4-en-3-one
|
fluoximesterona
|
ChEBI
|
fluoxymestérone
|
ChEBI
|
fluoxymesterone
|
ChemIDplus
|
fluoxymesteronum
|
ChEBI
|
11β,17β-Dihydroxy-9α-fluoro-17α-methyl-4-androster-3-one
|
ChemIDplus
|
17α-Methyl-9α-fluoro-11β-hydroxytesterone
|
ChemIDplus
|
9-Fluoro-11β,17β-dihydroxy-17-methylandrost-4-en-3-one
|
ChemIDplus
|
9α-Fluoro-11β-hydroxy-17-methyltestosterone
|
ChemIDplus
|
Testosterone, 9-fluoro-11beta-hydroxy-17-methyl-
|
ChemIDplus
|
2008796
|
Beilstein Registry Number
|
Beilstein
|
76-43-7
|
CAS Registry Number
|
ChemIDplus
|
|